Evidence map›Paper›PMID 32851407›Full record

ArticleInternational journal of epidemiology2020

Mismatch between poor fetal growth and rapid postnatal weight gain in the first 2 years of life is associated with higher blood pressure and insulin resistance without increased adiposity in childhood: the GUSTO cohort study.

Yi Ying Ong, Suresh Anand Sadananthan, Izzuddin M Aris, Mya Thway Tint, Wen Lun Yuan, Jonathan Y Huang, Yiong Huak Chan, Sharon Ng, See Ling Loy, Sendhil S Velan and 17 more

Erratum issued Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in International journal of epidemiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT07349966 (A Prospective Observational Study of the Impact of Blastocyst Biopsy on Postnatal Growth in Children Born After Preimplantation Genetic Testing), which is not on this map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
14.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07349966 enrolling by invitationnot on this mapstarted 2026, after this paper: background citation

A Prospective Observational Study of the Impact of Blastocyst Biopsy on Postnatal Growth in Children Born After Preimplantation Genetic Testing

Typeobservational_patient_registrySponsorIRCCS San RaffaeleRan2026 to 2028Enrolled330ConditionsPreimplantation Genetic Testing (PGT), Frozen Embryo Transfer Cycle, Assisted Reproduction Technologies, Postnatal HealthArmsQuestionnaire
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Fetal Growth Trajectories and Measures of Insulin Resistance in Young Adults.The Journal of clinical endocrinology and metabolism · 2023
    Article
  15. Long-term implications of fetal growth restriction.World journal of clinical cases · 2023
    Review
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 6 institutions in 5 countries.

Yi Ying OngDepartment of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Suresh Anand SadananthanSingapore Institute for Clinical Sciences, Agency for Science, Technology, and Research, Singapore, Singapore.
Izzuddin M ArisDivision of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.
Mya Thway TintSingapore Institute for Clinical Sciences, Agency for Science, Technology, and Research, Singapore, Singapore.
Wen Lun YuanDepartment of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Jonathan Y HuangSingapore Institute for Clinical Sciences, Agency for Science, Technology, and Research, Singapore, Singapore.
Yiong Huak ChanBiostatistics Unit, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Sharon NgDepartment of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
See Ling LoySingapore Institute for Clinical Sciences, Agency for Science, Technology, and Research, Singapore, Singapore.
Sendhil S VelanSingapore Institute for Clinical Sciences, Agency for Science, Technology, and Research, Singapore, Singapore.
Marielle V FortierSingapore Institute for Clinical Sciences, Agency for Science, Technology, and Research, Singapore, Singapore.
Keith M GodfreyMRC Lifecourse Epidemiology Unit and NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Lynette ShekDepartment of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Kok Hian TanDuke-NUS Medical School, Singapore, Singapore.
Peter D GluckmanSingapore Institute for Clinical Sciences, Agency for Science, Technology, and Research, Singapore, Singapore.
Fabian YapDuke-NUS Medical School, Singapore, Singapore.
Jonathan Tze Liang ChooDepartment of Pediatrics, KK Women's and Children's Hospital, Singapore, Singapore.
Lieng Hsi LingDepartment of Cardiology, National University Heart Centre, Singapore, Singapore.
Karen TanSingapore Institute for Clinical Sciences, Agency for Science, Technology, and Research, Singapore, Singapore.
Li ChenSingapore Institute for Clinical Sciences, Agency for Science, Technology, and Research, Singapore, Singapore.
Neerja KarnaniSingapore Institute for Clinical Sciences, Agency for Science, Technology, and Research, Singapore, Singapore.
Yap-Seng ChongSingapore Institute for Clinical Sciences, Agency for Science, Technology, and Research, Singapore, Singapore.
Johan G ErikssonSingapore Institute for Clinical Sciences, Agency for Science, Technology, and Research, Singapore, Singapore.
Mary E WlodekSingapore Institute for Clinical Sciences, Agency for Science, Technology, and Research, Singapore, Singapore.
Shiao-Yng ChanSingapore Institute for Clinical Sciences, Agency for Science, Technology, and Research, Singapore, Singapore.
Yung Seng LeeDepartment of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Navin MichaelSingapore Institute for Clinical Sciences, Agency for Science, Technology, and Research, Singapore, Singapore.
Agency for Science, Technology and Research · SGNational University of Singapore · SGKK Women's and Children's Hospital · SGHarvard University · USNational University Heart Centre Singapore · SGUniversity Hospital Southampton NHS Foundation Trust · GB

Funding

British Heart Foundation RG/15/17/31749Medical Research Council MC_UU_12011/4
6 · The paper itself

Abstract

backgroundUsing longitudinal ultrasounds as an improved fetal growth marker, we aimed to investigate if fetal growth deceleration followed by rapid postnatal weight gain is associated with childhood cardiometabolic risk biomarkers in a contemporary well-nourished population.

methodsWe defined fetal growth deceleration (FGD) as ultrasound-measured 2nd-3rd-trimester abdominal circumference decrease by ≥0.67 standard deviation score (SDS) and rapid postnatal weight gain (RPWG) as 0-2-year-old weight increase by ≥0.67 SDS. In the GUSTO mother-offspring cohort, we grouped 797 children into four groups of FGD-only (14.2%), RPWG-only (23.3%), both (mismatch, 10.7%) or neither (reference, 51.8%). Adjusting for confounders and comparing with the reference group, we tested associations of these growth groups with childhood cardiometabolic biomarkers: magnetic resonance imaging (MRI)-measured abdominal fat (n = 262), liver fat (n = 216), intramyocellular lipids (n = 227), quantitative magnetic resonance-measured overall body fat % (BF%) (n = 310), homeostasis model assessment of insulin resistance (HOMA-IR) (n = 323), arterial wall thickness (n = 422) and stiffness (n = 443), and blood pressure trajectories (ages 3-6 years).

resultsMean±SD birthweights were: FGD-only (3.11 ± 0.38 kg), RPWG-only (3.03 ± 0.37 kg), mismatch (2.87 ± 0.31 kg), reference (3.30 ± 0.36 kg). FGD-only children had elevated blood pressure trajectories without correspondingly increased BF%. RPWG-only children had altered body fat partitioning, higher BF% [BF = 4.26%, 95% confidence interval (CI) (2.34, 6.19)], HOMA-IR 0.28 units (0.11, 0.45)] and elevated blood pressure trajectories. Mismatch children did not have increased adiposity, but had elevated ectopic fat, elevated HOMA-IR [0.29 units (0.04,0.55)] and the highest blood pressure trajectories. Associations remained even after excluding small-for-gestational-age infants from analyses.

conclusionsFetal growth deceleration coupled with rapid postnatal weight gain was associated with elevated childhood cardiometabolic risk biomarkers without correspondingly increased BF%.

Indexed as

AdiposityInsulin ResistanceBlood PressureBody Mass IndexChildChild, PreschoolCohort StudiesFetal DevelopmentHumansInfantInfant, NewbornWeight Gainadiposityblood pressurebody compositioncardiometabolic riskcardiovascularCohort studyfetal growthinsulin resistancemismatchpostnatal growth

Identifiers

PMID32851407
PMCPMC7116531
OpenAlexW3080805910

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.